These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7890718)

  • 1. Sialic acid content of plasminogen 2 glycoforms as a regulator of fibrinolytic activity. Isolation, carbohydrate analysis, and kinetic characterization of six glycoforms of plasminogen.
    Pirie-Shepherd SR; Jett EA; Andon NL; Pizzo SV
    J Biol Chem; 1995 Mar; 270(11):5877-81. PubMed ID: 7890718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the murine plasma fibrinolytic system.
    Lijnen HR; van Hoef B; Beelen V; Collen D
    Eur J Biochem; 1994 Sep; 224(3):863-71. PubMed ID: 7523120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator.
    Mori K; Dwek RA; Downing AK; Opdenakker G; Rudd PM
    J Biol Chem; 1995 Feb; 270(7):3261-7. PubMed ID: 7852411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of the process of Glu-plasminogen activation by tissue activator with fibrin, DDE-complex, and D-dimer using alpha-2-antiplasmin].
    Hrynenko TV; Zadorozhna MB; Platonova TM; Volkov HL
    Ukr Biokhim Zh (1999); 2005; 77(5):45-51. PubMed ID: 16846069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of alpha 2-antiplasmin in the inhibition of clot lysis in newborns and adults.
    Ries M; Klinge J; Rauch R; Keuper H; Harms D
    Biol Neonate; 1996; 69(5):298-306. PubMed ID: 8790908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of physiological fibrinolysis.
    Lijnen HR; Collen D
    Baillieres Clin Haematol; 1995 Jun; 8(2):277-90. PubMed ID: 7549063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
    Edelberg JM; Pizzo SV
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D; Anglés-Cano E
    Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro.
    Fredenburgh JC; Nesheim ME
    J Biol Chem; 1992 Dec; 267(36):26150-6. PubMed ID: 1464625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N; Iwamoto M; Abiko Y
    Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
    Urano S; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
    Ries M; Zenker M; Gaffney PJ
    Thromb Res; 2000 Nov; 100(4):341-51. PubMed ID: 11113278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of staphylokinase with different molecular forms of plasminogen.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1993 Jan; 211(1-2):91-7. PubMed ID: 8425556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elements of the fibrinolytic system.
    Lijnen HR
    Ann N Y Acad Sci; 2001; 936():226-36. PubMed ID: 11460480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM; Kalnoski MH; Frederick M; Chandler WL
    Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of the affinity chromatography forms of human Glu- and Lys-plasminogens and plasmins.
    Summaria L; Spitz F; Arzadon L; Boreisha IG; Robbins KC
    J Biol Chem; 1976 Jun; 251(12):3693-9. PubMed ID: 132440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An elastase-dependent pathway of plasminogen activation.
    Machovich R; Owen WG
    Biochemistry; 1989 May; 28(10):4517-22. PubMed ID: 2504279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.